Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type III secretion system protein refers collectively to the integrated set of highly conserved proteins composing the Type III secretion system (T3SS), a syringe-like nanomachine utilized by many Gram-negative pathogenic bacteria to inject virulence effector proteins directly into the cytoplasm of eukaryotic host cells[1][2][3][4][7][8]. The T3SS itself is made up of over 20 structural and functional protein components forming the needle complex (basal body, needle, export apparatus, and sorting platform), as well as several auxiliary chaperones and ATPases required for the energy-dependent export of unfolded effector proteins. These proteins play a critical role in bacterial pathogenicity by facilitating colonization, immune evasion, and manipulation of host cell function, and are fundamentally required for the infectivity of pathogens such as *Salmonella*, *Shigella*, *Yersinia*, *Pseudomonas*, and pathogenic *Escherichia coli*[1][3][4][5][6][7][8]. Due to their essential role in disease, T3SS proteins are recognized as promising antibacterial targets, though no specific drugs have reached clinical approval as of yet. **Note:** - "Type III secretion system protein" is not a single protein but a class representing components of the secretion system complex[7][8]. - Individual core proteins (e.g., the needle protein, ATPase, chaperones) may be drug targets, but often literature refers to the system collectively as a virulence apparatus[1][4][8]. - If you require a specific T3SS subunit (e.g., "Type III secretion needle protein"), please specify for more granular information.
Inhibition of T3SS assembly Blockade of effector protein secretion Inhibition of T3SS ATPase activity Targeting the needle protein or basal body interaction
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type III secretion system protein (T3SS protein).